Loading provider…
Loading provider…
Cardiovascular Disease Physician in Reno, NV
NPI: 1225358666HQ Phone
Get M.D. Jay's Phone Numberphone_androidMobile
Get M.D. Jay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNV State Medical License
KY State Medical License
CA State Medical License
UT State Medical License
NV State Medical License
1986 - 2027
CA State Medical License
1973 - 2026
KY State Medical License
1999 - 2026
UT State Medical License
1983 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease
Stanford Health Care-Sponsored Stanford University
Fellowship • Cardiovascular Disease
1974 - 1976
Internship • Internal Medicine
1973 - 1974
Residency • Internal Medicine
1972 - 1972
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1972
The Myocarditis Treatment Trial: design, methods and patient enrolment
Authors: Ahvie Herskowitz
Publication Date: 1995-12
Implications of the ESVEM trial for use of antiarrhythmic drugs that prolong cardiac repolarization
Authors: Jay W. Mason
Publication Date: 1993-11
Authors: Olshansky, B, Hartz, V, Hahn, E, Mason, J, Weaver, M D
Journal: Am J Cardiol
Lead Sponsor: Haiyan Li
Collaborators: Food and Drug Administration (FDA), Spaulding Clinical Research LLC, BioClinica, Inc., Peking University
Intervention / Treatment: DRUG: Moxifloxacin
Lead Sponsor: University of Utah
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: prednisone, DRUG: cyclosporine